| Food and Drug Administration (FDA) |
0 |
0.82 |
| Precocious Puberty |
0 |
0.39 |
| Revenue and Practice Management |
0 |
0.39 |
| Puberty |
0 |
0.33 |
| Insurance |
0 |
0.22 |
| Health Insurance |
0 |
0.19 |
| Child |
0 |
0.17 |
| Shock |
0 |
0.17 |
| Dorsum |
0 |
0.11 |
| Drug Shortage |
0 |
0.11 |
| Social Determinants of Health |
0 |
0.1 |
| Gender Dysphoria |
0 |
0.09 |
| Birth |
0 |
0.06 |
| Brachial |
0 |
0.06 |
| COVID-19 |
0 |
0.06 |
| Endocrinology |
0 |
0.06 |
| Gender Identity |
0 |
0.06 |
| Health Care Facilities, Manpower, and Services |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Indiana |
0 |
0.06 |
| Match |
0 |
0.06 |
| Medical Life |
0 |
0.06 |
| Metabolism |
0 |
0.06 |
| Nonprofit Organizations |
0 |
0.06 |
| Off-Label Use |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Traction |
0 |
0.06 |
| Utah |
0 |
0.06 |